A comparison of visual analog scale and categorical ratings of headache pain in a randomized controlled clinical trial with migraine patients

[1]  Ferrari,et al.  Guidelines for Controlled Trials of Drugs in Migraine: Second Edition , 2000, Cephalalgia : an international journal of headache.

[2]  A J Dowson,et al.  Unbalanced Randomization Influences Placebo Response: Scientific Versus Ethical Issues Around the Use of Placebo in Migraine Trials , 1999, Cephalalgia : an international journal of headache.

[3]  C. Spencer,et al.  Zolmitriptan: a review of its use in migraine. , 1999, Drugs.

[4]  D. Dulli,et al.  Naratriptan: An Alternative for Migraine , 1999, The Annals of pharmacotherapy.

[5]  C. Lines,et al.  Rizatriptan: a new 5-HT1B/1D receptor agonist for the treatment of migraine. , 1999, Expert opinion on investigational drugs.

[6]  C. Lines,et al.  Crossover Comparison of Rizatriptan 5 mg and 10 mg Versus Sumatriptan 25 mg and 50 mg in Migraine , 1998, Headache.

[7]  M. Giacovazzo,et al.  Oral Rizatriptan Versus Oral Sumatriptan: A Direct Comparative Study in the Acute Treatment of Migraine , 1998, Headache.

[8]  C. Perry,et al.  Sumatriptan. An updated review of its use in migraine. , 1998, Drugs.

[9]  V. Pfaffenrath,et al.  Efficacy and Safety of Sumatriptan Tablets (25 mg, 50 mg, and 100 mg) in the Acute Treatment of Migraine: Defining the Optimum Doses of Oral Sumatriptan , 1998, Headache.

[10]  K. Hoppu,et al.  Sumatriptan for migraine attacks in children , 1997, Neurology.

[11]  E. Skovlund,et al.  Response Measures in the Acute Treatment of Migraine , 1995, Cephalalgia : an international journal of headache.

[12]  H. Diener,et al.  Low-Dose Ibuprofen in Self-Medication of Mild to Moderate Headache: A Comparison with Acetylsalicylic Acid and Placebo , 1995, Cephalalgia : an international journal of headache.

[13]  D. Yealy,et al.  Randomized, placebo-controlled evaluation of prochlorperazine versus metoclopramide for emergency department treatment of migraine headache. , 1995, Annals of emergency medicine.

[14]  C. Dahlöf,et al.  Diclofenac-K (50 and 100 mg) and Placebo in the Acute Treatment of Migraine , 1993, Cephalalgia : an international journal of headache.

[15]  L. Milne.  Treatment of migraine attacks with sumatriptan. The Subcutaneous Sumatriptan International Study Group. , 1992, The New England journal of medicine.

[16]  P. Tfelt-Hansen.  Guidelines for Controlled Trials of Drugs in Migraine. First Edition , 1991 .

[17]  A. Pilgrim.  Methodology of clinical trials of sumatriptan in migraine and cluster headache. , 1991, European neurology.

[18]  V. Pfaffenrath,et al.  Flunarizine (10 and 20 mg) i.v. Versus Placebo in the Treatment of Acute Migraine Attacks: A Multi-Centre Double-Blind Study , 1990, Cephalalgia : an international journal of headache.

[19]  Giuseppe Orefice,et al.  Flunarizine in Prophylaxis of Childhood Migraine: A Double-Blind, Placebo-Controlled, Crossover Study , 1988, Cephalalgia : an international journal of headache.

[20]  G. Littman,et al.  Reassessment of verbal and visual analog ratings in analgesic studies , 1985, Clinical pharmacology and therapeutics.